$ADPT
Adaptive Biotechnologies Corporation Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$28.61
▲+0.21%+$0.060
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAdaptive Biotechnologies Corporation Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is ADPT up today? It is at $28.61 (+0.21%), and our scanner flagged it 92 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ADPT spikes, and full due diligence on ADPT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ADPT 92 times in the last 30 days. Create a free account to track $ADPT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ADPT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ADPT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystAdaptive Biotechnologies Corp: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Statement of changes in beneficial ownership of securitiesSep 19, 2026 · 2 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Bobulsky Susan Officer | Sold (automatic/other) | -1K | sold 0.3% | 396K | $32K at $27.00 | Sep 15, 26 |
Owen Katey Einterz Director | Sold (automatic/other) | -13K | sold 16% | 66K | n/a | Aug 31, 26 |
Owen Katey Einterz Director | Sold (automatic/other) | -10K | sold 11% | 79K | $250K at $26.00 | Aug 26, 26 |
Robins Chad M Officer | Sold (automatic/other) | -279K 0.2% of company | sold 11% | 2.18M | $6.8M at $24.48 | Aug 18, 26 |
Robins Chad M Officer | Other | 279K 0.2% of company | added 13% | 2.46M | $1.8M at $6.55 | Aug 18, 26 |
Hershberg Robert Director | Sold (automatic/other) | -31K 0.02% of company | sold 40% | 47K | $748K at $24.39 | Aug 18, 26 |
Hershberg Robert Director | Other | 15K | added 24% | 77K | $95K at $6.32 | Aug 18, 26 |
Neupert Peter M Director | Sold (automatic/other) | -125K 0.08% of company | sold 49% | 131K | $3.1M at $25.10 | Aug 17, 26 |
Neupert Peter M Director | Other | 15K | added 6.2% | 255K | $95K at $6.32 | Aug 17, 26 |
Robins Chad M Officer | Sold (automatic/other) | -321K 0.2% of company | sold 13% | 2.18M | $8.1M at $25.08 | Aug 17, 26 |
Robins Chad M Officer | Other | 321K 0.2% of company | added 15% | 2.50M | $2.1M at $6.55 | Aug 17, 26 |
Bobulsky Susan Officer | Sold (automatic/other) | -3K | sold 0.8% | 397K | $75K at $25.00 | Aug 10, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on ADPT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ADPT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ADPT last traded at $28.61, up 0.21% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Adaptive Biotechnologies Corporation Common Stock (ADPT) is next expected to report earnings on Wednesday, November 4, 2026, about 45 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ADPT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ADPT 92 times in the last 30 days.
ADPT (Adaptive Biotechnologies Corporation Common Stock) trades on XNAS, with a market cap of about $4.57B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ADPT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ADPT discussion
Sign in to ask a question or join the discussion.